{"disease":{"id":"stem-cell-transplant","name":"stem cell transplant"},"drugs":{"marketed":[{"drug_id":"nyvepria","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neulasta","generic_name":"Pegfilgrastim-Apgf","company_name":"Amgen","drug_phase":"marketed","molecular_target":"G-CSF receptor on hematopoietic cells","drug_class":"Colony-stimulating factor","quality_score":10,"revenue":"1200","mechanism":"Colony-stimulating factor binding hematopoietic cell surface receptors to stimulate proliferation and differentiation."},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Autologous Stem Cell Transplantation for the Treatment of HIV","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"campath","indication_name":"Conditioning treatment prior to allogeneic haematopoietic stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Campath","company_name":"National Heart, Lung, and Blood Institute (NHLBI)","drug_phase":"marketed","molecular_target":"CAMPATH-1 antigen","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"pegfilgrastim-jmdb","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULPHILA","generic_name":"PEGFILGRASTIM-JMDB","company_name":"MYLAN GMBH","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"busilvex","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Busilvex","company_name":"medac GmbH","drug_phase":"phase_2","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"mycophenolate-mofetil","indication_name":"The suppression of graft-versus-host disease in hematopoietic stem cell transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cellcept","generic_name":"MYCOPHENOLATE MOFETIL","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":"Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides."},{"drug_id":"daratumumab-and-hyaluronidase-fihj","indication_name":"Multiple Myeloma in combination with bortezomib, lenalidomide, and dexamethasone for induction and consolidation in newly diagnosed patients who are eligible for autologous stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Darzalex Faspro","generic_name":"daratumumab-and-hyaluronidase-fihj","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"CD38","drug_class":"CD38-directed Cytolytic Antibody [EPC]","quality_score":63,"revenue":null,"mechanism":"Daratumumab and Hyaluronidase-fihj is a monoclonal antibody that targets CD38, a transmembrane glycoprotein on the surface of hematopoietic cells."},{"drug_id":"daratumumab-and-hyaluronidase-fihj","indication_name":"Multiple Myeloma in combination with bortezomib, lenalidomide, and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Darzalex Faspro","generic_name":"daratumumab-and-hyaluronidase-fihj","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"CD38","drug_class":"CD38-directed Cytolytic Antibody [EPC]","quality_score":63,"revenue":null,"mechanism":"Daratumumab and Hyaluronidase-fihj is a monoclonal antibody that targets CD38, a transmembrane glycoprotein on the surface of hematopoietic cells."},{"drug_id":"daratumumab-and-hyaluronidase-fihj","indication_name":"Multiple Myeloma in combination with bortezomib, melphalan and prednisone in newly diagnosed patients who are ineligible for autologous stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Darzalex Faspro","generic_name":"daratumumab-and-hyaluronidase-fihj","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"CD38","drug_class":"CD38-directed Cytolytic Antibody [EPC]","quality_score":63,"revenue":null,"mechanism":"Daratumumab and Hyaluronidase-fihj is a monoclonal antibody that targets CD38, a transmembrane glycoprotein on the surface of hematopoietic cells."},{"drug_id":"daratumumab-and-hyaluronidase-fihj","indication_name":"Multiple Myeloma in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant and in patients with relapsed or refractory multiple myeloma who have received at least one prior therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Darzalex Faspro","generic_name":"daratumumab-and-hyaluronidase-fihj","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"CD38","drug_class":"CD38-directed Cytolytic Antibody [EPC]","quality_score":63,"revenue":null,"mechanism":"Daratumumab and Hyaluronidase-fihj is a monoclonal antibody that targets CD38, a transmembrane glycoprotein on the surface of hematopoietic cells."},{"drug_id":"daratumumab-and-hyaluronidase-fihj","indication_name":"Multiple Myeloma in combination with bortezomib, thalidomide, and dexamethasone in newly diagnosed patients who are eligible for autologous stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Darzalex Faspro","generic_name":"daratumumab-and-hyaluronidase-fihj","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"CD38","drug_class":"CD38-directed Cytolytic Antibody [EPC]","quality_score":63,"revenue":null,"mechanism":"Daratumumab and Hyaluronidase-fihj is a monoclonal antibody that targets CD38, a transmembrane glycoprotein on the surface of hematopoietic cells."},{"drug_id":"pegfilgrastim","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neulasta","generic_name":"PEGFILGRASTIM","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":70,"revenue":null,"mechanism":"Neulasta stimulates the production of white blood cells by binding to their receptors."},{"drug_id":"alemtuzumab","indication_name":"Conditioning treatment prior to allogeneic haematopoietic stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Campath","generic_name":"ALEMTUZUMAB","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"CAMPATH-1 antigen","drug_class":"CD52-directed Cytolytic Antibody [EPC]","quality_score":10,"revenue":null,"mechanism":"Campath works by binding to a specific protein on the surface of immune cells, marking them for destruction."},{"drug_id":"busulfan","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Busulfex","generic_name":"busulfan","company_name":"Waylis","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9","drug_class":"Alkylating Drug [EPC]","quality_score":10,"revenue":null,"mechanism":"Busulfex works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death."},{"drug_id":"treosulfan","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trecondi","generic_name":"TREOSULFAN","company_name":"Medexus","drug_phase":"marketed","molecular_target":"","drug_class":"treosulfan","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"neulasta","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neulasta","company_name":"Columbia University","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"busulfex","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"busulfex","company_name":"Dana-Farber Cancer Institute","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"narsoplimab","indication_name":"hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Yartemlea","generic_name":"NARSOPLIMAB","company_name":"Omeros Corp","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Narsoplimab works by targeting and modulating the immune system to prevent damage to blood vessels."},{"drug_id":"busulphan","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Busulphan","company_name":"University of Birmingham","drug_phase":"discontinued","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":19,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07349498","title":"Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07328724","title":"Critical Illness After Hematopoietic Cell Transplantation","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06708130","title":"Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT04469985","title":"Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey","phase":"","overall_status":"COMPLETED","enrollment_count":2061,"lead_sponsor_name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","has_results":false},{"nct_id":"NCT03000244","title":"Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04386928","title":"ALLO-SCT in Elderly Patients With Hematological Disease","phase":"","overall_status":"COMPLETED","enrollment_count":1996,"lead_sponsor_name":"Gruppo Italiano Trapianto di Midollo Osseo","has_results":false},{"nct_id":"NCT04412811","title":"Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT","phase":"","overall_status":"COMPLETED","enrollment_count":1310,"lead_sponsor_name":"Gruppo Italiano Trapianto di Midollo Osseo","has_results":false},{"nct_id":"NCT04937400","title":"Delirium in Children Undergoing Stem Cell Transplantation","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1040,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT07297914","title":"Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Bambino Gesù Hospital and Research Institute","has_results":false},{"nct_id":"NCT07205523","title":"High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Yigeng Cao,MD,PhD","has_results":false},{"nct_id":"NCT04888286","title":"DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors","phase":"","overall_status":"COMPLETED","enrollment_count":912,"lead_sponsor_name":"Gruppo Italiano Trapianto di Midollo Osseo","has_results":false},{"nct_id":"NCT03357172","title":"Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT02181413","title":"A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":656,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT00674882","title":"Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant","phase":"","overall_status":"COMPLETED","enrollment_count":637,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT03641378","title":"Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"COMPLETED","enrollment_count":546,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT05103995","title":"Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":510,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT07028112","title":"Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04786002","title":"Target Busulfan Exposure in Children With HSCT in China","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT06386445","title":"Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT05722210","title":"Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT04788420","title":"Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML","phase":"","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06673459","title":"BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":430,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05579639","title":"Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":419,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03449953","title":"Critical Care Outcomes of Hematologic Oncology Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":415,"lead_sponsor_name":"Mount Sinai Hospital, Canada","has_results":false},{"nct_id":"NCT03800758","title":"Expressive Helping for Stem Cell Transplant Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":405,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT07442513","title":"Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":404,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT07157670","title":"Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04690933","title":"AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT06328127","title":"Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06791746","title":"Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":388,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT05421299","title":"A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate","phase":"","overall_status":"COMPLETED","enrollment_count":378,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06960993","title":"Mosaic Trial for Stem Cell Transplant Recipients","phase":"NA","overall_status":"RECRUITING","enrollment_count":356,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04674345","title":"Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":346,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03482154","title":"Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population","phase":"","overall_status":"COMPLETED","enrollment_count":344,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT05290545","title":"Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03850379","title":"Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"Henry Ford Health System","has_results":true},{"nct_id":"NCT06541002","title":"A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05355675","title":"The Association of Microbiota Composition With cGVHD After Allo-HSCT","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT04619147","title":"Invasive Fungal Infections in Patients Following Stem Cell Transplant","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Peter MacCallum Cancer Centre, Australia","has_results":false},{"nct_id":"NCT07490392","title":"Growth and Endocrinological Outcomes in Patients Who Underwent or Did Not Undergo Haematopoietic Stem Cell Transplantation in Prepubertal Age","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07210242","title":"HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Ting YANG","has_results":false},{"nct_id":"NCT07286461","title":"VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":290,"lead_sponsor_name":"University of Rome Tor Vergata","has_results":false},{"nct_id":"NCT04203108","title":"ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":266,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06198517","title":"Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT","phase":"NA","overall_status":"RECRUITING","enrollment_count":266,"lead_sponsor_name":"Yi Zhang","has_results":false},{"nct_id":"NCT05814731","title":"Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT","phase":"NA","overall_status":"UNKNOWN","enrollment_count":264,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT05436418","title":"The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03689465","title":"PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":260,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT01521039","title":"Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease","phase":"","overall_status":"COMPLETED","enrollment_count":259,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04623424","title":"Intestinal Microbiota in Stem Cell Transplant Transplant Admission","phase":"","overall_status":"RECRUITING","enrollment_count":255,"lead_sponsor_name":"Henry Ford Health System","has_results":false},{"nct_id":"NCT03865589","title":"Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Children's Mercy Hospital Kansas City","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}